Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant Enterococci

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 10, 1998, Pages 734-736

  Tripodi, M F ^a   Locatelli, A ^a   Adinolfi, L E ^a   Andreana, A ^a   Utili, R ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; GENTAMICIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; DRUG EFFICACY; ENTEROCOCCUS; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECALIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH;

AGED; AMPICILLIN; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS; FLUOROQUINOLONES; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS;

EID: 0032421603     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050171     Document Type: Article

References (10)

1. 1. Moellering RC: The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. Journal of Antimicrobial Chemotherapy (1991) 28:1-12
2. 2. Dass SS, Anderson JR, Macdonald AA, Somerville KW: Endocarditis due to high level gentamicin resistant Enterococcus faecium. Journal of Infection (1994) 28:185-191
3. 3. Landman D, Mobarakai NK, Quale JM: Novel antibiotic regimen against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrobial Agents and Chemotherapy (1993) 37:1904-1908
4. 4. Tripodi MF, Utili R, Rambaldi A, Locatelli A, Rosario P, Florio A, Ruggiero G: Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci. Journal of Antimicrobial Chemotherapy (1996) 37:727-736
5. 5. Landman D, Quale JM, Mobarakai N, Zaman MM: Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy (1995) 36:253-258
6. 6. Drake TA, Hackbarth CJ, Sande MA: Value of serum tests in combined drug therapy of endocarditis. Antimicrobial Agents and Chemotherapy (1983) 24:653-657
7. 7. Tripodi MF, Locatelli A, Rambaldi A, Rosario P, Utili R: In-vitro activity of combined ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium: influence of the medium on susceptibility test results. Journal of Antimicrobial Chemotherapy (1998) 41:139-140
8. 8. Arduino RC, Murray BE, Rakita RM: Roles of antibodies and complement in phagocytic killing of enterococci. Infection and Immunity (1994) 62:987-993
9. 9. Lee PY, Das SS: Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis. Postgraduate Medical Journal (1995) 71:117-119
10. 10. Sacher HL, Miller WC, Landau SW, Sacher ML, Dixon WA, Dietrich KA: Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy. Journal of Clinical Pharmacology (1991) 31:719-721